🕵️ Eikon Therapeutics, Inc. ($EIKN)
SEC insider & ownership activity, last 12 months · CIK 1861123 · every row links its SEC filing
Over the last 12 months insiders bought $51.1M with no open-market selling against it. The Column Group IV GP, LP bought $38.1M in discretionary trades (Feb). No red-flag 8-Ks in the window.
Insider flow
5 buyers, $51.1M (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| The Column Group IV GP, LP | 3 | $38.1M | 0 | – | Feb 6, 2026 |
| LUX Venture Partners V, LLC | 2 | $5.0M | 0 | – | Feb 4, 2026 |
| Wolfe Josh | 2 | $5.0M | 0 | – | Feb 4, 2026 |
| Kenneth C. Frazier | 1 | $2.0M | 0 | – | Feb 4, 2026 |
| Foresite Capital Management IV, LLC | 1 | $1000K | 0 | – | Feb 4, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Tim Kutzkey | 11.6% | 13D | Feb 6, 2026 | filing ↗ | |
| Peter Svennilson | 11.6% | 13D | Feb 6, 2026 | filing ↗ | |
| The Column Group IV GP, LP | 8.3% | 13D | Feb 6, 2026 | filing ↗ | |
| The Column Group IV, LP | 8.0% | 13D | Feb 6, 2026 | filing ↗ | |
| James B. Tananbaum | 7.7% | 13G | Feb 11, 2026 | filing ↗ | |
| FMR LLC | 7.1% | 13G | May 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 7.1% | 13G | May 6, 2026 | filing ↗ | |
| Blackrock Portfolio Management LLC | 5.5% | 13G | Apr 29, 2026 | filing ↗ | |
| Abu Dhabi Investment Authority | 5.2% | 13G | Feb 18, 2026 | filing ↗ | |
| Roger M. Perlmutter | 5.2% | 13G | May 13, 2026 | filing ↗ | |
| Innovation Endeavors III LP | 5.0% | 13G | May 15, 2026 | filing ↗ | |
| Innovation Endeavors III GP, LLC | 5.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 30, 2026 | filing ↗ |
| Other events (8.01) | May 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 30, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 6, 2026 | filing ↗ |